Drug for fungal infections in lung transplant recipients increases risk for cancer, death

(University of California - San Francisco) Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news